In human acute myeloid leukemia (AML), activation of TIM-3 works through NF-κB and β-catenin signaling pathways to promote self-renewal of leukemic stem cells (Kikushige et al., 2015). This evidence concerns the gene NFKB1 and acute myeloid leukemia.